Strategies for a two-step liver fibrosis assessment in clinical practice

Strategies for a two-step liver fibrosis assessment in clinical practice

Bibliographic Details
Main Authors:	Lai, M. (Author), Vieira Barbosa, J. (Author)
Format:	Article
Language:	English
Published:	Elsevier B.V. 2022
Subjects:	clinical practice digestive system disease assessment FIB-4 Fibrosis 4 Score glycemic control human Letter liver fibrosis medical society NAFLD non insulin dependent diabetes mellitus nonalcoholic fatty liver patient care patient navigator T2DM transient elastography
Online Access:	View Fulltext in Publisher

Similar Items

NONALCOHOLIC FATTY LIVER DISEASE: COMORBIDITIES, CLINICAL SIGNIFICANCE AND EVALUATION OF LIVER FIBROSIS
by: D. V. Marshalko, et al.
Published: (2018-02-01)

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
by: Rommel Zambrano-Huailla, et al.
Published: (2020-11-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
by: Chan, W.-K, et al.
Published: (2022)

Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
by: I. V. Maev, et al.
Published: (2020-02-01)

The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan
by: Lee YS, et al.
Published: (2021-03-01)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
by: Panyavee Pitisuttithum, et al.
Published: (2020-04-01)

Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients
by: Valentina Li Vecchi, et al.
Published: (2013-09-01)

Metabolic Syndrome Is Associated With Advanced Liver Fibrosis Among Pediatric Patients With Non-alcoholic Fatty Liver Disease
by: Yi-Wen Ting, et al.
Published: (2019-11-01)

Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-Analysis
by: Federico Salomone, et al.
Published: (2018-08-01)

Combination of transient elastography with serum-based non-invasive tests improves prediction of liver fibrosis in patients with chronic hepatitis C: a prospective cohort study
by: Romanas Zykus, et al.
Published: (2015-08-01)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
by: Dedong Huang, et al.
Published: (2019-10-01)

Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome
by: Silvia Bettini, et al.
Published: (2021-04-01)

Estimating steatosis and fibrosis
by: Karlas, Thomas, et al.
Published: (2015)

Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
by: O M Drapkina, et al.
Published: (2016-02-01)

Validation of a two‐step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis
by: Hideki Fujii, et al.
Published: (2021-07-01)

Association between serum and dietary antioxidant micronutrients and advanced liver fibrosis in non-alcoholic fatty liver disease: an observational study
by: Juliana Moraes Coelho, et al.
Published: (2020-09-01)

Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
by: Chao Sang, et al.
Published: (2021-02-01)

Non-invasive methods for the diagnosis of liver fibrosis in chronic HCV-infection
by: A. I. Fazul’zyanova, et al.
Published: (2021-03-01)

Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance
by: Takuma Hasegawa, et al.
Published: (2020-05-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
by: José Tadeu Stefano, et al.
Published: (2021-01-01)

Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
by: Diego García-Compeán, et al.
Published: (2020-05-01)

Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography
by: Adele Taibbi, et al.
Published: (2021-07-01)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
by: Stefano Ciardullo, et al.
Published: (2021-07-01)

Non-invasive diagnostic methods of the liver fibrosis in patients with overweigh and obesity
by: Nadiia Gavryliuk, et al.
Published: (2021-03-01)

Elevated red cell distribution width is associated with advanced fibrosis in NAFLD
by: Hwa Mok Kim, et al.
Published: (2013-09-01)

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients
by: Ivana Mikolasevic, et al.
Published: (2014-09-01)

A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones
by: Yu-Tsung Chou, et al.
Published: (2021-03-01)

The reverse of the coin: Methotrexate and liver fibrosis in a group of psoriatic arthritis patients
by: Andreea Lili Barbulescu, et al.
Published: (2020-12-01)

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
by: Rodrigo Bremer Nones, et al.
Published: (2017-02-01)

The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals
by: Fayed HM, et al.
Published: (2020-02-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Relationship between serum ferritin level and transient elastography findings among patients with nonalcoholic fatty liver disease
by: Seyed Saeed Seyedian, et al.
Published: (2017-01-01)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
by: Gwyneth Soon, et al.
Published: (2021-01-01)

The Use of Two-Dimensional Shear Wave Elastography in People with Obesity for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Ritesh Chimoriya, et al.
Published: (2021-12-01)

Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
by: Somaya Albhaisi
Published: (2019-09-01)

Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?
by: Somaya Albhaisi
Published: (2019-05-01)

Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects
by: Alba Martínez-Escudé, et al.
Published: (2021-03-01)

Assessment of hepatic fibrosis in patients with rheumatoid arthritis on long-term methotrexate therapy using transient elastography
by: Abhishek Kumar, et al.
Published: (2018-01-01)